Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 729 - 736 of 12008 results
Telephone and Texting Compliance News: Regulatory Update — FCC Announces Meeting of the North American Numbering Council
June 28, 2024| Article| Viewpoint
Telephone and Texting Compliance News: Litigation Update — Fourth Circuit Adds to TCPA Case Law at Appellate and District Court Levels
June 28, 2024| Article| Viewpoint
New York State Now Requires Paid Lactation Breaks
June 28, 2024| Blog| Viewpoint
Supreme Court in Jarkesy Limits the SEC’s Powers to Use In-House Administrative Courts
June 28, 2024| Blog| Viewpoint
Implementing AI: Practical Steps for Advisers and Broker-Dealers Deploying AI Compliance Tools Amidst Regulatory Uncertainty
June 27, 2024| Webinar| Viewpoint
Colorado AI Systems Regulation: What Health Care Deployers and Developers Need to Know
June 27, 2024| Blog| Viewpoint
Protecting Trade Secrets In US, EU Gov't Agency Submissions
June 26, 2024| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|